Abstract:[Objective] To compare the clinical efficacy of tenodesis of biceps long head tendon versus repair in situ for type II superiorlabrum anterior to posterior (SLAP) tear. [Methods] Clinical data of 31 patients with type II SLAP injury admitted to our hospital from Janu-ary 2018 to June 2021 were retrospectively analyzed. According to the results of doctor-patient communication, 16 patients were treatedwith tenodesis of biceps long head tendon (tenodesis group), while other 15 patients were treated with repair in situ by suture anchor (the re-pair group). The perioperative period and follow-up results of the two groups were compared. [Results] The operation was successfully com-pleted in both groups, with no significant differences in operation time, incision length, intraoperative blood loss, active activity time, inci-sion healing and hospital stay between the two groups (P>0.05). All patients in both groups were followed for more than 1 year, and therewas no significant difference in the time to regain full weight-bearing activities between the two groups (P>0.05). As time went by, the VAS,ASES, QuickDASH and Constant-Murley scores were significantly improved in both groups (P<0.05). The tenodesis group proved signifi-cantly superior to the repair group regarding the VAS score 3 months after surgery [(2.5±0.5) vs (3.7±1.0), P<0.001]. Moreover, the tenode-sis group was significantly better than the repair group in terms of ASES [(93.7±1.8) vs (90.3±3.3), P=0.002], QuickDASH [(8.9±1.9) vs(11.0±1.6), P=0.002] and Constant-Murley scores [(93.8±1.5) vs (91.1±3.1), P=0.006] at the last follow-up, although the difference in VASscores between the two groups became not statistically significant at that time (P>0.05). [Conclusion] Both biceps long head tenodesis andrepair in situ by suture anchor do achieve satisfactory outcomes in the treatment of type II SLAP injury. In comparison, the biceps long headtenodesis is superior to the repair in situ in terms of experience and efficacy more than six months after surgery.